Skip to main navigation
Skip to main content
Dice Logo
  • About
  • Approach
  • Pipeline
  • Patients
  • Investors
  • Careers

Unlocking the potential of oral medicines

Creating massive opportunities through the development of high-impact oral small molecule medicines for chronic autoimmune and inflammatory diseases.

About Us
  • Investors |
  • Overview

Investors


Investor Relations

  • Overview
  • News and Events
    • News Releases
    • Events
  • Corporate Presentation
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
  • Financial Information
    • SEC Filings
    • Annual Reports & Proxy
  • Investor Resources

Common Stock

Feb 4, 2023 1:14 AM EST

Data Provided by Refinitiv.

Minimum 15 minutes delayed.




Learn About Stock

Latest News

Jan 04, 2023

DICE Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

Nov 09, 2022

DICE Therapeutics Reports Third Quarter 2022 Financial Results and Recent Highlights

Nov 03, 2022

DICE Therapeutics to Present at Upcoming Investor Conferences
View All News

DICE Corporate
Presentation

Latest Events

Jan 12, 2023 |   3:00 PM EST

41st Annual J.P. Morgan Healthcare Conference

Nov 30, 2022 |   3:05 PM EST

Evercore ISI 5th Annual HealthCONx Conference
View All Events

Contact Us

investors@dicetx.com

Subscribe to Investor Email Alerts

Get new updates directly to your inbox

Subscribe
Dice logo
  • Careers
  • News
  • Contact Us
  • Privacy Policy
  • Terms of Use
400 East Jamie Court
Suite 300
South San Francisco
CA 94080
DICE Therapeutics ©2023
LinkedIn logo